Literature DB >> 14550259

Modulation of delayed rectifier potassium current by angiotensin II in CATH.a cells.

Chengwen Sun1, Jiangqing Du, Mohan K Raizada, Colin Sumners.   

Abstract

Angiotensin II (Ang II) modulates, via Ang II type 1 (AT(1)) receptors, the activity of brain catecholaminergic neurons. Here we utilized catecholaminergic CATH.a cells to define the effects of Ang II on delayed rectifier K(+) current (I(Kv)), one of the factors that determines changes in neuronal activation. Receptor binding analyses demonstrated the presence of AT(1) receptors in CATH.a cells. Whole cell voltage clamp experiments in these cells revealed that Ang II (100nM) produced a significant inhibition of I(Kv), that was abolished by the AT(1) receptor blocker, losartan (1 microM), or by inhibition of phospholipase C (PLC) with U73122 (10 microM). Furthermore, this action of Ang II was completely abolished by co-inhibition of protein kinase C (PKC) and calcium/calmodulin protein kinase II (CaMKII). These results demonstrate that Ang II produces an inhibition of I(Kv) in CATH.a cells, via an intracellular pathway that includes PLC, PKC, and CaMKII.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550259     DOI: 10.1016/j.bbrc.2003.09.069

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase.

Authors:  Erin G Rosenbaugh; James W Roat; Lie Gao; Rui-Fang Yang; Devika S Manickam; Jing-Xiang Yin; Harold D Schultz; Tatiana K Bronich; Elena V Batrakova; Alexander V Kabanov; Irving H Zucker; Matthew C Zimmerman
Journal:  Biomaterials       Date:  2010-04-07       Impact factor: 12.479

2.  Pressor effect of apelin-13 in the rostral ventrolateral medulla: role of NAD(P)H oxidase-derived superoxide.

Authors:  Fanrong Yao; Amit Modgil; Qi Zhang; Ajeeth Pingili; Neha Singh; Stephen T O'Rourke; Chengwen Sun
Journal:  J Pharmacol Exp Ther       Date:  2010-11-03       Impact factor: 4.030

3.  Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.

Authors:  Krupa Savalia; Devika S Manickam; Erin G Rosenbaugh; Jun Tian; Iman M Ahmad; Alexander V Kabanov; Matthew C Zimmerman
Journal:  Free Radic Biol Med       Date:  2014-06-09       Impact factor: 7.376

4.  Mitochondrial-localized NADPH oxidase 4 is a source of superoxide in angiotensin II-stimulated neurons.

Authors:  Adam J Case; Shumin Li; Urmi Basu; Jun Tian; Matthew C Zimmerman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-26       Impact factor: 4.733

5.  Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism.

Authors:  Rui-Fang Yang; Jing-Xiang Yin; Yu-Long Li; Matthew C Zimmerman; Harold D Schultz
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-27       Impact factor: 4.249

6.  Intrinsic plasticity induced by group II metabotropic glutamate receptors via enhancement of high-threshold KV currents in sound localizing neurons.

Authors:  W R Hamlet; Y Lu
Journal:  Neuroscience       Date:  2016-03-08       Impact factor: 3.590

Review 7.  Angiotensin II and angiotensin-1-7 redox signaling in the central nervous system.

Authors:  Matthew C Zimmerman
Journal:  Curr Opin Pharmacol       Date:  2011-01-21       Impact factor: 5.547

8.  The modulation of voltage-gated potassium channels by anisotonicity in trigeminal ganglion neurons.

Authors:  L Chen; C Liu; L Liu
Journal:  Neuroscience       Date:  2008-03-29       Impact factor: 3.590

9.  Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current.

Authors:  Jing-Xiang Yin; Rui-Fang Yang; Shumin Li; Alex O Renshaw; Yu-Long Li; Harold D Schultz; Matthew C Zimmerman
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-20       Impact factor: 4.249

Review 10.  Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases.

Authors:  Erin G Rosenbaugh; Krupa K Savalia; Devika S Manickam; Matthew C Zimmerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-03       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.